Original Source(s)
Related Content
Can SGLT2 Inhibitors Affect Dementia?
A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.
July 31, 2026
-
3 min
FDA approves first therapy for Alexander disease
The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.
September 4, 2026
-
2 min